» Articles » PMID: 5576726

Factors Determining Cell Killing by Chemotherapeutic Agents in Vivo. II. Melphalan, Chlorambucil and Nitrogen Mustard

Overview
Specialty Oncology
Date 1971 Feb 1
PMID 5576726
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Bertheau P, Turpin E, Rickman D, Espie M, De Reynies A, Feugeas J PLoS Med. 2007; 4(3):e90.

PMID: 17388661 PMC: 1831731. DOI: 10.1371/journal.pmed.0040090.


Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.

Shepherd R, HARRAP K Br J Cancer. 1982; 45(3):413-20.

PMID: 7073935 PMC: 2010934. DOI: 10.1038/bjc.1982.69.


Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Yagi M, Zanjani M, HOLLAND J, BEKESI J Cancer Chemother Pharmacol. 1984; 12(2):77-82.

PMID: 6697428 DOI: 10.1007/BF00254593.


Interphase cell death as related to the cell cycle of melphalan-treated human myeloma cells.

Fernberg J, Lewensohn R, Skog S Med Oncol Tumor Pharmacother. 1991; 8(2):63-7.

PMID: 1749301 DOI: 10.1007/BF02988855.


Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

Irons R, Stillman W, Colagiovanni D, Henry V Proc Natl Acad Sci U S A. 1992; 89(9):3691-5.

PMID: 1570288 PMC: 525556. DOI: 10.1073/pnas.89.9.3691.